The Nucleocapsid Protein of SARS-CoV-2 : a Target for Vaccine Development
| Errataetall: |
CommentOn: Antiviral Res. 2014 Mar;103:39-50. - PMID 24418573 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:94 |
|---|---|
| Enthalten in: |
Journal of virology - 94(2020), 13 vom: 16. Juni |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dutta, Noton K [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Comment |
|---|
| Anmerkungen: |
Date Completed 24.06.2020 Date Revised 07.12.2022 published: Electronic-Print CommentOn: Antiviral Res. 2014 Mar;103:39-50. - PMID 24418573 Citation Status MEDLINE |
|---|
| doi: |
10.1128/JVI.00647-20 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311253989 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311253989 | ||
| 003 | DE-627 | ||
| 005 | 20231225141848.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1128/JVI.00647-20 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1037.xml |
| 035 | |a (DE-627)NLM311253989 | ||
| 035 | |a (NLM)32546606 | ||
| 035 | |a (PII)e00647-20 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dutta, Noton K |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Nucleocapsid Protein of SARS-CoV-2 |b a Target for Vaccine Development |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.06.2020 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Electronic-Print | ||
| 500 | |a CommentOn: Antiviral Res. 2014 Mar;103:39-50. - PMID 24418573 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a coronavirus disease 2019 (COVID-19) | |
| 650 | 4 | |a nucleocapsid protein | |
| 650 | 4 | |a severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2) | |
| 650 | 4 | |a vaccine | |
| 650 | 7 | |a Nucleocapsid Proteins |2 NLM | |
| 700 | 1 | |a Mazumdar, Kaushiki |e verfasserin |4 aut | |
| 700 | 1 | |a Gordy, James T |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of virology |d 1967 |g 94(2020), 13 vom: 16. Juni |w (DE-627)NLM000006866 |x 1098-5514 |7 nnns |
| 773 | 1 | 8 | |g volume:94 |g year:2020 |g number:13 |g day:16 |g month:06 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1128/JVI.00647-20 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 94 |j 2020 |e 13 |b 16 |c 06 | ||